Alnylam and Cubist form R&D collaboration (Pharmaceutical Business Review) PDF Print

Alnylam Pharmaceuticals, an RNAi therapeutics company, and Cubist Pharmaceuticals, an acute care biopharmaceutical company, have formed a strategic collaboration to develop and commercialize Alnylams ALN-RSV program.

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.